SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-056593
Filing Date
2021-04-28
Accepted
2021-04-28 16:30:39
Documents
2
Period of Report
2021-04-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2114485-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2114485-1_3seq1.xml 3 1621
2 EXHIBIT 24 tm2114485d1_ex24.htm EX-24 8725
  Complete submission text file 0001104659-21-056593.txt   11816
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERULEAN PHARMA INC. 840 MEMORIAL DRIVE, 5TH FLOOR CAMBRIDGE MA 02139
Business Address
Carvajal Alejandra (Reporting) CIK: 0001645755 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38129 | Film No.: 21864683